Ben Kong, Pharm.D. (he/him)

  • Adjunct Faculty - Oregon State University College of Pharmacy
  • OHSU Knight Cancer Institute, School of Medicine

Biography

Dr. Kong is a clinical pharmacist specialized in pharmacogenetics in both germline (hereditary) and somatic (cancer) mutations.  He completed his general residency at Providence and specialized residency at the University of Florida Health System.  He has experience in implementation initiatives and in applying the information to better optimize medication based on a patient's genetic profile.  

Education and training

    • Pharm.D., 2012, Oregon State University / Oregon Health & Science University

  • Residency

    • PGY2 (clinical pharmacogenetics) - University of Florida
    • PGY1 (hospital) - Providence Medical Center

  • Certifications

    • Board Certified Pharmacotherapy Specialist (BCPS)

Memberships and associations:

  • Clinical Pharmacogenetics Implementation Consortium (CPIC)
  • Standardizing Laboratory Practices in Pharmacogenomics (STRIPE)
  • Pharmacogenomics Research Network (PGRN)

Areas of interest

  • Pharmacogenetics, pharmacogenomics, personalized medicine, precision medicine, cancer

Publications

Publications

  • {{ pub.journalAssociation.journal.name.text[0].value }}